Aggressive brain cancer may respond to high-dose vitamin therapy, study suggests

 https://www.foxnews.com/health/aggressive-brain-cancer-may-respond-high-dose-vitamin-therapy-study-suggests

High-dose vitamin B3 (niacin) may enhance immune activity and improve short-term disease control in glioblastoma when added to standard therapy, according to early preclinical studies.

Six months after receiving niacin in addition to standard treatments (surgery, radiation and chemotherapy), 82% of the patients showed no disease progression, compared to the typical 54%, according to the study's press release.

The study’s small sample size, short follow-up and lack of a randomized control group also posed limitations, the researchers acknowledged.